These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 14533729)

  • 41. Syringe availability as HIV prevention: a review of modalities.
    Coffin P
    J Urban Health; 2000 Sep; 77(3):306-30. PubMed ID: 10976607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon.
    Ghaddar A; Nassar K; Elsoury G
    Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Torian LV; Beatice S; Semaan S; Friedman SR
    Drug Alcohol Depend; 2010 Jun; 109(1-3):154-60. PubMed ID: 20163922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Syringe source, use, and discard among injection-drug users in New Haven, Connecticut.
    Khoshnood K; Blankenship KM; Pollack HA; Roan CT; Altice FL
    AIDS Public Policy J; 2000; 15(3-4):88-94. PubMed ID: 12189714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Back-calculation based on HIV and AIDS registers in Denmark, Norway and Sweden 1977-95 among homosexual men: estimation of absolute rates, incidence rates and prevalence of HIV.
    Amundsen EJ; Aalen OO; Stigum H; Eskild A; Smith E; Arneborn M; Nilsen O; Magnus P
    J Epidemiol Biostat; 2000; 5(4):233-43. PubMed ID: 11055273
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should pharmacists sell sterile syringes to injection drug users?
    Jones TS; Taussig J
    J Am Pharm Assoc (Wash); 1999; 39(1):8-10. PubMed ID: 9990178
    [No Abstract]   [Full Text] [Related]  

  • 47. Legal harm reduction among intravenous drug users.
    Kongsakon R; Pocham N
    J Med Assoc Thai; 2006 Sep; 89(9):1545-50. PubMed ID: 17100399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV prevention among injection drug users: the need for integrated models.
    Metzger DS; Navaline H
    J Urban Health; 2003 Dec; 80(4 Suppl 3):iii59-66. PubMed ID: 14713672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water.
    McCoy CB; Metsch LR; Chitwood DD; Shapshak P; Comerford ST
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S25-9. PubMed ID: 9663620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services.
    Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Beatrice S; Milliken J; Mildvan D; Yancovitz S; Friedman SR
    Am J Public Health; 2005 Aug; 95(8):1439-44. PubMed ID: 15985649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes.
    Bruneau J; Daniel M; Kestens Y; Zang G; Généreux M
    J Epidemiol Community Health; 2008 Sep; 62(9):804-10. PubMed ID: 18701731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Access to syringes in three Russian cities: implications for syringe distribution and coverage.
    Sarang A; Rhodes T; Platt L
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S25-36. PubMed ID: 18313910
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.
    Wiessing L; Likatavicius G; Klempová D; Hedrich D; Nardone A; Griffiths P
    Am J Public Health; 2009 Jun; 99(6):1049-52. PubMed ID: 19372511
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Historical perspective on the use of bleach in HIV/AIDS prevention.
    Watters JK
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):743-6. PubMed ID: 8207657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of users of syringe vending machines in Berlin.
    Stark K; Leicht A; Müller R
    Soz Praventivmed; 1994; 39(4):209-16. PubMed ID: 7941771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour.
    Hartgers C; Buning EC; van Santen GW; Verster AD; Coutinho RA
    AIDS; 1989 Sep; 3(9):571-6. PubMed ID: 2506902
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh?
    Foss AM; Watts CH; Vickerman P; Azim T; Guinness L; Ahmed M; Rodericks A; Jana S
    Addiction; 2007 Jan; 102(1):114-25. PubMed ID: 17207129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Needle and syringe exchange programmes and prevalence of HIV infection among intravenous drug users in China.
    Luo W; Wu Z; Poundstone K; McGoogan JM; Dong W; Pang L; Rou K; Wang C; Cao X
    Addiction; 2015 Jan; 110 Suppl 1():61-7. PubMed ID: 25533865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A study on the risk and its determinants of HIV transmission by syringe sharing among HIV-positive drug users].
    Bao Y; Zhang Y; Liang Y; Chen M; Sun J; Tan H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):513-7. PubMed ID: 26310336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.